Lymphoma
iwNHL Session V: novel therapies in NHL – the role of ADCs
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 16th December 2022
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 30th November 2022
iwNHL Session III: exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 18th November 2022
iwNHL Session II: understanding and harnessing the immune microenvironment against lymphoma
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 9th November 2022
iwNHL 2022 Session I: advances in the treatment of T-cell lymphoma
The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in…
Date: 26th October 2022
CAR-T therapy in myeloma and lymphoma
CAR-T therapy has revolutionized the treatment landscape of several hematological malignancies, and ongoing clinical trials continue to provide valuable data…
Date: 12th August 2022
The current state of CAR-T therapy in lymphoma
Over the last few decades, advances in immunotherapies including CAR-T therapy have revolutionized the treatment of patients with relapsed/refractory (R/R)…
Date: 5th August 2022
The future of CAR-T therapy in ALL
Acute lymphoblastic leukemia (ALL) is an aggressive and heterogeneous disease with a high mortality rate. However, several advances have been…
Date: 20th July 2022
Updates in lymphoma and CLL treatment in the UK
In recent years, there have been many advances in the treatment of lymphoma and chronic lymphocytic leukemia (CLL) in the…
Date: 17th June 2022
CAR-T and lymphoma treatment in the UK
Lymphoma treatment has seen many recent advances, with CAR-T therapy being a game changer for patients. Several clinical trials investigating…
Date: 27th May 2022
ASH 2021: the future of cell therapies in lymphoma
Cell therapies including chimeric antigen receptor (CAR) T-cell therapy represent novel treatments for patients with lymphoma, especially for those who…
Date: 25th February 2022
The Lymphoma Sessions: post-ASH 2021
The 63rd American Society of Hematology (ASH) annual meeting saw a plethora of updates in lymphoma. While most of them…
Date: 2nd February 2022
